Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.


Updates from The Motley Fool

Latest updates on Myriad Genetics from Fool.com.


Stock Performance

MYGN vs. S&P 500 | 2 Year Performance
View Interactive MYGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Myriad Genetics.
Current Price: $20.70
Prev Close: $20.70
Open: $21.51
Bid: $20.75
Ask: $23.40
Day's Range: $20.67 - $21.57
52wk Range: $19.10 - $46.24
Volume: 1,742,850
Avg Vol 1,647,389
Market Cap: $1.44B
P/E (ttm): 12.62
EPS (ttm): $1.71
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Myriad Genetics.
CAPS Rating 4 out of 5
 
528 Outperform
87 Underperform
CAPS All Stars
 
112 Outperform
13 Underperform

How do you think Myriad Genetics will perform against the market?



You pick for Myriad Genetics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark C. Capone, CEO

88% Approve

Based on 21 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Myriad Genetics.

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services